Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-16-017130
Filing Date
2016-09-29
Accepted
2016-09-29 13:03:03
Documents
1
Period of Report
2016-09-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4092016leire_dandrit.html 4  
1 OWNERSHIP DOCUMENT f4092016leire_dandrit.xml 4 3733
  Complete submission text file 0001213900-16-017130.txt   5267
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Issuer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DANDRIT BIOTECH USA, INC. P.O. BOX 189 RANDOLPH VT 05060
Business Address
Leire, Eric Jean Marie (Reporting) CIK: 0001600390 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54478 | Film No.: 161909018